Krystal Biotech (KRYS) Competitors $170.74 -6.65 (-3.75%) (As of 11/15/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends KRYS vs. BCRX, NK, ALEC, TSHA, PRQR, TEVA, BGNE, MRNA, VTRS, and SMMTShould you be buying Krystal Biotech stock or one of its competitors? The main competitors of Krystal Biotech include BioCryst Pharmaceuticals (BCRX), NantKwest (NK), Alector (ALEC), Taysha Gene Therapies (TSHA), ProQR Therapeutics (PRQR), Teva Pharmaceutical Industries (TEVA), BeiGene (BGNE), Moderna (MRNA), Viatris (VTRS), and Summit Therapeutics (SMMT). These companies are all part of the "medical" sector. Krystal Biotech vs. BioCryst Pharmaceuticals NantKwest Alector Taysha Gene Therapies ProQR Therapeutics Teva Pharmaceutical Industries BeiGene Moderna Viatris Summit Therapeutics Krystal Biotech (NASDAQ:KRYS) and BioCryst Pharmaceuticals (NASDAQ:BCRX) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, valuation, community ranking, media sentiment, dividends, risk, profitability and institutional ownership. Do institutionals and insiders believe in KRYS or BCRX? 86.3% of Krystal Biotech shares are held by institutional investors. Comparatively, 85.9% of BioCryst Pharmaceuticals shares are held by institutional investors. 14.1% of Krystal Biotech shares are held by insiders. Comparatively, 4.8% of BioCryst Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Does the MarketBeat Community prefer KRYS or BCRX? BioCryst Pharmaceuticals received 197 more outperform votes than Krystal Biotech when rated by MarketBeat users. However, 67.14% of users gave Krystal Biotech an outperform vote while only 66.53% of users gave BioCryst Pharmaceuticals an outperform vote. CompanyUnderperformOutperformKrystal BiotechOutperform Votes28667.14% Underperform Votes14032.86% BioCryst PharmaceuticalsOutperform Votes48366.53% Underperform Votes24333.47% Which has more volatility & risk, KRYS or BCRX? Krystal Biotech has a beta of 0.82, suggesting that its share price is 18% less volatile than the S&P 500. Comparatively, BioCryst Pharmaceuticals has a beta of 1.89, suggesting that its share price is 89% more volatile than the S&P 500. Is KRYS or BCRX more profitable? Krystal Biotech has a net margin of 21.68% compared to BioCryst Pharmaceuticals' net margin of -30.01%. Krystal Biotech's return on equity of 7.54% beat BioCryst Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Krystal Biotech21.68% 7.54% 6.97% BioCryst Pharmaceuticals -30.01%N/A -24.06% Does the media favor KRYS or BCRX? In the previous week, Krystal Biotech had 2 more articles in the media than BioCryst Pharmaceuticals. MarketBeat recorded 7 mentions for Krystal Biotech and 5 mentions for BioCryst Pharmaceuticals. BioCryst Pharmaceuticals' average media sentiment score of 0.87 beat Krystal Biotech's score of 0.62 indicating that BioCryst Pharmaceuticals is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Krystal Biotech 4 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive BioCryst Pharmaceuticals 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts prefer KRYS or BCRX? Krystal Biotech currently has a consensus price target of $197.00, indicating a potential upside of 15.38%. BioCryst Pharmaceuticals has a consensus price target of $14.67, indicating a potential upside of 108.63%. Given BioCryst Pharmaceuticals' higher possible upside, analysts plainly believe BioCryst Pharmaceuticals is more favorable than Krystal Biotech.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Krystal Biotech 0 Sell rating(s) 1 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 3.00BioCryst Pharmaceuticals 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.83 Which has better earnings and valuation, KRYS or BCRX? Krystal Biotech has higher earnings, but lower revenue than BioCryst Pharmaceuticals. BioCryst Pharmaceuticals is trading at a lower price-to-earnings ratio than Krystal Biotech, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioKrystal Biotech$50.70M96.85$10.93M$1.7796.46BioCryst Pharmaceuticals$331.41M4.39-$226.54M-$0.61-11.52 SummaryKrystal Biotech beats BioCryst Pharmaceuticals on 14 of the 19 factors compared between the two stocks. Ad Genesis Gold GroupTrump’s Back, but DC’s Coming for Your Money!Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy with a heavy hand—building up infrastructure, slapping tariffs on imports, and going all-in on U.S. jobs. But here's the kicker: while Trump's focused on making America stronger, the Washington elite is ready to fight back…Get ahead of the game with 3 proven strategies to protect your retirement from Washington's next mov Get Krystal Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for KRYS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart KRYS vs. The Competition Export to ExcelMetricKrystal BiotechBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.91B$2.94B$5.12B$8.72BDividend YieldN/A1.81%5.18%4.07%P/E Ratio96.4620.4872.8114.16Price / Sales96.85224.491,250.2081.71Price / CashN/A176.6640.7036.03Price / Book5.544.056.455.94Net Income$10.93M-$42.42M$119.73M$225.73M7 Day Performance-14.46%-10.63%-5.13%-1.34%1 Month Performance-3.44%-5.81%-2.71%1.15%1 Year Performance63.92%24.19%31.08%24.02% Krystal Biotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)KRYSKrystal Biotech4.7252 of 5 stars$170.74-3.7%$197.00+15.4%+73.6%$4.91B$50.70M96.46229BCRXBioCryst Pharmaceuticals4.2114 of 5 stars$7.45-2.5%N/A+36.8%$1.54B$331.41M-12.21530Short Interest ↓NKNantKwestN/A$4.83-2.4%N/A+9.8%$528.14M$40,000.00-6.80160High Trading VolumeALECAlector4.3865 of 5 stars$4.91-4.1%N/A+3.2%$480.84M$97.06M-2.89270News CoverageTSHATaysha Gene Therapies3.8865 of 5 stars$2.27+2.7%N/A+31.2%$465.22M$12.87M-11.35180Analyst ForecastNews CoverageGap UpHigh Trading VolumePRQRProQR Therapeutics2.3708 of 5 stars$3.95-0.3%N/A+169.0%$322.64M$15.41M-12.34180Short Interest ↑Analyst RevisionGap UpTEVATeva Pharmaceutical Industries2.7975 of 5 stars$16.75-1.1%N/A+87.6%$18.98B$15.85B-19.7137,851Gap DownBGNEBeiGene3.0741 of 5 stars$193.29-1.1%N/A+0.0%$18.83B$2.46B-23.4610,600Earnings ReportAnalyst ForecastShort Interest ↓Analyst RevisionNews CoverageGap DownMRNAModerna4.5631 of 5 stars$39.77-5.6%N/A-51.9%$15.30B$5.06B-6.835,600Analyst ForecastOptions VolumeGap DownHigh Trading VolumeVTRSViatris1.3727 of 5 stars$12.62-2.9%N/A+39.9%$15.06B$15.43B-17.0538,000Insider SellingSMMTSummit Therapeutics2.1933 of 5 stars$19.45-0.1%N/A+884.4%$14.34B$700,000.00-69.46105Gap Up Related Companies and Tools Related Companies BCRX Alternatives NK Alternatives ALEC Alternatives TSHA Alternatives PRQR Alternatives TEVA Alternatives BGNE Alternatives MRNA Alternatives VTRS Alternatives SMMT Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:KRYS) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Krystal Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Krystal Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free KRYS Stock Alerts